HER2 Support Group Forums - View Single Post - Neoprobe seeks FDA marketing approval of Lymphoseek for use in ILM oncology procedure

News · 08-10-2011, 09:40 PM

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced it has submitted a New Drug Application (NDA) for Lymphoseek to the U.S. Food and Drug Administration.

More...

08-10-2011, 09:40 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,981	Neoprobe seeks FDA marketing approval of Lymphoseek for use in ILM oncology procedure Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced it has submitted a New Drug Application (NDA) for Lymphoseek to the U.S. Food and Drug Administration. More...